Xeris Biopharma Holdings (XERS) Goodwill & Intangibles (2021 - 2025)
Historic Goodwill & Intangibles for Xeris Biopharma Holdings (XERS) over the last 5 years, with Q3 2025 value amounting to $113.6 million.
- Xeris Biopharma Holdings' Goodwill & Intangibles fell 870.99% to $113.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $113.6 million, marking a year-over-year decrease of 870.99%. This contributed to the annual value of $121.8 million for FY2024, which is 817.58% down from last year.
- Per Xeris Biopharma Holdings' latest filing, its Goodwill & Intangibles stood at $113.6 million for Q3 2025, which was down 870.99% from $116.4 million recorded in Q2 2025.
- Xeris Biopharma Holdings' Goodwill & Intangibles' 5-year high stood at $154.3 million during Q4 2021, with a 5-year trough of $113.6 million in Q3 2025.
- For the 5-year period, Xeris Biopharma Holdings' Goodwill & Intangibles averaged around $134.0 million, with its median value being $134.0 million (2023).
- Per our database at Business Quant, Xeris Biopharma Holdings' Goodwill & Intangibles crashed by 702.68% in 2022 and then tumbled by 870.99% in 2025.
- Xeris Biopharma Holdings' Goodwill & Intangibles (Quarter) stood at $154.3 million in 2021, then dropped by 7.03% to $143.5 million in 2022, then fell by 7.56% to $132.6 million in 2023, then fell by 8.18% to $121.8 million in 2024, then dropped by 6.68% to $113.6 million in 2025.
- Its Goodwill & Intangibles was $113.6 million in Q3 2025, compared to $116.4 million in Q2 2025 and $119.1 million in Q1 2025.